Teacher’s day special
*********
We wish everyone a happy Teacher’s day. On this special occasion, we are happy to announce that ideas posted today (05/September/2016) will be available to the use of Scientists/Professors/Physicians/Researchers for free.
So, there will be no terms and conditions for the ideas posted today (05/September/2016). Each idea posted will be served first come, first served basis.Write to info@genomediscovery.org for more details about the idea posted.
Dr L Boominathan PhD
CEO & CSO, GBMD.
A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March 2013 issue of Nature by Prof Dimmler, Boon, and others.
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Small ribonucleic acid medicine therapy for Myocardial Infarction: MiRNA-181b improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10)
Significance:
Given that: (1) cardiovascular disease is the leading cause of death worldwide; (2) in India, in 2004, 14.6 lakhs deaths (14% of total deaths) were due to ischemic heart disease; and (3) the global economic cost spent in the treatment of cardiovascular disease in 2011 was little more than 10 billion US dollars, there is an urgent need to find: (i) a way to induce regeneration of adult cardiomyocytes that were lost in Myocardial patients; (ii) a cheaper alternative to the existing expensive drugs; and (iii) a side-effect-free drug.
By increasing the expression of MiRNA-181b in cardiomyocytes, one may prevent ageing-associated (or, stress-associated) decline in cardiac function. Thus, this study suggests that pharmacological formulations encompassing “MiRNA-181b activators” may be used to improve cardiac function after myocardial infarction.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
To cite: Boominathan, Small ribonucleic acid medicine therapy for Myocardial Infarction: MiRNA-181b improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 5/September/2016, 11.00 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Undisclosed information: How MiRNA-181b increases the expression of PNUTS/PPP1R10